Macrophages, chemokines and neuronal injury in HIV-1-associated dementia
- PMID: 11995633
Macrophages, chemokines and neuronal injury in HIV-1-associated dementia
Abstract
Human immunodeficiency virus type-one (HIV- 1)-associated dementia (HAD) is manifested as a spectrum of behavioral, motor and cognitive dysfunctions. The disorder commonly occurs during late stage HIV disease and remains an important complication despite highly active antiretroviral therapies. A metabolic encephalopathy, fueled by neurotoxic secretions from brain mononuclear phagocytes (MP) (macrophages and microglia) underlies HIV- I neuropathogenesis. One pivotal question, however, is how brain MP evolve from neurotrophic to neurotoxic cells. The interplay between the virus, the macrophage and the neuron has just recently begun to be unraveled. Along with a multitude of other MP secretory products, chemokines effect neuronal function by engaging neuronal receptors then activating pathways that alter synaptic transmission, cell growth, injury and protection. Both neurons and glia secrete chemokines. Interestingly, HIV-1 and its gene products can mimic chemokine neuronal signaling by binding to neuronal chemokine receptors or by other non-specific mechanisms. The elucidation of mechanisms involved in chemokine-mediated neural compromise will likely provide unique insights into the pathogenesis and treatment, not only of HAD, but of a wide range of neurodegenerative disorders.
Similar articles
-
HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.J Neurovirol. 2000 May;6 Suppl 1:S14-23. J Neurovirol. 2000. PMID: 10871761 Review.
-
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.J Leukoc Biol. 2003 Nov;74(5):691-701. doi: 10.1189/jlb.0503205. J Leukoc Biol. 2003. PMID: 14595004 Review.
-
Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia.J Leukoc Biol. 2000 Sep;68(3):413-22. J Leukoc Biol. 2000. PMID: 10985259 Review.
-
HIV-1 infection and AIDS: consequences for the central nervous system.Cell Death Differ. 2005 Aug;12 Suppl 1:878-92. doi: 10.1038/sj.cdd.4401623. Cell Death Differ. 2005. PMID: 15832177 Review.
-
Pathways to neuronal injury and apoptosis in HIV-associated dementia.Nature. 2001 Apr 19;410(6831):988-94. doi: 10.1038/35073667. Nature. 2001. PMID: 11309629 Review.
Cited by
-
Gene expression patterns associated with neurological disease in human HIV infection.PLoS One. 2017 Apr 26;12(4):e0175316. doi: 10.1371/journal.pone.0175316. eCollection 2017. PLoS One. 2017. PMID: 28445538 Free PMC article.
-
Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS.J Neurovirol. 2008 Aug;14(4):327-39. doi: 10.1080/13550280802132840. J Neurovirol. 2008. PMID: 18780234 Free PMC article. Review.
-
Classification of HIV-1-mediated neuronal dendritic and synaptic damage using multiple criteria linear programming.Neuroinformatics. 2004;2(3):303-26. doi: 10.1385/ni:2:3:303. Neuroinformatics. 2004. PMID: 15365193
-
HIV-1-infected astrocytes and the microglial proteome.J Neuroimmune Pharmacol. 2008 Sep;3(3):173-86. doi: 10.1007/s11481-008-9110-x. Epub 2008 Jun 28. J Neuroimmune Pharmacol. 2008. PMID: 18587649 Free PMC article.
-
CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy.FASEB J. 2009 Sep;23(9):2928-41. doi: 10.1096/fj.08-128819. Epub 2009 Apr 20. FASEB J. 2009. PMID: 19380511 Free PMC article.